Market footprint Hartmann Group operates in over 130 countries with a broad portfolio across incontinence management, wound care, and infection management, indicating demand across healthcare settings worldwide and opportunities for cross-category sales conversations.

Expansion momentum Recent and ongoing investments in production expansions and new lines (hydrocellular dressings Evolution line; France site expansion; newer products like twopress 2 Lite and colactive PLUS powders) signal capacity for increased manufacturing partnerships and OEM collaborations.

Digital backbone Adoption of SAP S/4HANA, Celum DAM, Informa, and other enterprise tools suggests strong process efficiency, enabling scalable order management, data-driven account planning, and faster onboarding of new customers.

Sustainability focus Transformation program launched since 2019 aims to sustainably improve competitiveness, aligning with modern procurement goals and potential for sustainability-aligned product packaging or waste-reduction projects appealing to health systems and distributors.

Strategic positioning Longstanding brand portfolio with established stalwarts like MoliCare, Zetuvit, Cosmopor, and Sterillium positions Hartmann as a trusted supplier for hospitals, long-term care, and infection control, presenting consultative selling opportunities around bundled solutions and service add-ons.